[1]张跃伟,刘 影,任志忠,等.微粒- TACE同步治疗肝癌伴Ⅲ型门静脉癌栓6例 [J].介入放射学杂志,2018,27(12):1186-1189.
　ZHANG Yuewei,LIU Ying,REN Zhizhong,et al.GSMs- TACE simultaneous therapy for hepatocellular carcinoma with type Ⅲ portal vein tumor thrombus： initial results in 6 patients[J].journal interventional radiology,2018,27(12):1186-1189.
点击复制

微粒- TACE同步治疗肝癌伴Ⅲ型门静脉癌栓6例 
()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
27
期数:
2018年12期
页码:
1186-1189
栏目:
临床研究
出版日期:
2018-12-25

文章信息/Info

Title:
GSMs- TACE simultaneous therapy for hepatocellular carcinoma with type Ⅲ portal vein tumor thrombus： initial results in 6 patients
作者:
张跃伟;  刘 影;  任志忠;  岳元勋;  韩东冬
Author(s):
ZHANG Yuewei;  LIU Ying;  REN Zhizhong;  YUE Yuanxun;  HAN Dongdong.
Department of Hepatobiliary Intervention， Affiliated Beijing Tsinghua Changgung Hospital， School of Clinical Medicine， Tsinghua University， Beijing 102218， China
关键词:
【关键词】 肝癌;  门静脉癌栓;  明胶海绵微粒;  化疗栓塞
文献标志码:
A
摘要:
【摘要】 目的 探讨应用明胶海绵微粒经肝动脉化疗栓塞（GSMs- TACE）同步治疗肝癌伴Ⅲ型门静脉癌栓患者的安全性及临床疗效。方法 应用GSMs- TACE治疗6例Ⅲ型伴门静脉癌栓肝癌患者。患者Child- Pugh分级均为A级。术后结合影像学改变、AFP下降情况、肝功损伤情况、生存时间及术后不良反应综合评估安全性及临床疗效。结果 6例患者共行介入22（2～5）次GSM- TACE，中位介入次数为4次；中位随访时间16.5（9～33）个月，6个月后6例患者均生存，术后均无急性肝衰竭、上消化道出血等严重并发症发生。结论 应用GSMs- TACE同步治疗Child- Pugh分级A级的肝癌伴Ⅲ型门静脉癌栓患者，具备良好的安全性及临床疗效。

参考文献/References:

［1］ Llovet JM， Bustamante J， Castells A， et al. Natural history of untreated nonsurgical hepatocellular carcinoma： rationale for the design and evaluation of therapeutic trials［J］. Hepatology， 1999， 29： 62- 67.
［2］ Silva JP， Berger NG， Tsai S， et al. Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis： a systematic review and meta- analysis［J］. HPB（Oxford）， 2017， 19： 659- 666.
［3］ Chung GE， Lee JH， Kim HY， et al. Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival［J］. Radiology， 2011， 258： 627- 634.
［4］ Onishi H， Nouso K， Nakamura S， et al. Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion［J］. Hepatol Int， 2015， 9： 105- 112.
［5］ He MK， Zou RH， Li QJ， et al. Phase Ⅱ study of sorafenib combined with concurrent hepatic arterial infusion of oxaliplatin， 5- fluorouracil and leucovorin for unresectable hepatocellular carcinoma with major portal vein thrombosis［J］. Cardiovasc Intervent Radiol， 2018， 41： 734- 743.
［6］ Fujino H， Kimura T， Aikata H， et al. Role of 3- D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma［J］. Hepatol Res， 2014， 45： 607- 617.
［7］ Zhang X， Wang K， Wang M， et al. Transarterial chemoembo- lization（TACE） combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus： a systematic review and meta- analysis［J］. Oncotarget， 2017， 8： 29416- 29427.
［8］ Huo YR， Eslick GD. Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma： a systematic review and meta- analysis［J］. JAMA Oncol， 2015， 1： 756- 765.
［9］ 杨雪玲， 于海鹏， 郭 志. 载药微球在肝癌经动脉化疗栓塞治疗中的应用研究新进展［J］. 中华医学杂志， 2016， 96： 589- 592.
［10］ Zuo MX， Huang JH. The history of interventional therapy for liver cancer in China［J］. J Intervent Med， 2018， 1： 70- 76.
［11］ Kamran AU， Liu Y， Li FE， et al. Transcatheter arterial chemoembolization with gelatin sponge microparticles treated for BCLC stage B hepatocellular carcinoma： a single center retrospective study［J］. Medicine（Baltimore）， 2015， 94： e2154.
［12］ Liu Y， Zhang Y， Bautista D， et al. Trans- arterial p53- gene- embolization with gelatin sponge microparticles for hepatocellular carcinoma with BCLC stage B： single- center experience［J］. Cell Biochem Biophys， 2014， 71： 99- 104.
［13］ 张跃伟， 刘 影， 徐 克， 等. 明胶海绵微粒经导管肝动脉化疗栓塞治疗原发性肝癌疗效分析［J］. 中华肝脏病杂志， 2013， 21： 637- 638.
［14］ 周 军， 张跃伟， 赵广生， 等. 微粒联合重组人P53腺病毒注射液栓塞治疗晚期肝癌疗效观察［J］. 中华医学杂志， 2014， 94： 660- 663.
［15］ Zhou J， Liu Y， Ren Z， et al. Transarterial chemoembolization with gelatin sponge microparticles for Barcelona clinic liver cancer Stage C and large hepatocellular carcinoma： initial clinical experience［J］. J Cancer Res Ther， 2017， 13： 767- 772.
［16］ 中华人民共和国国家卫生和计划生育委员会． 原发性肝癌诊疗规范（2017 年版）［J］. 临床肝胆病杂志， 2017， 33： 1419- 1431．
［17］ Niu ZJ， Ma YL， Kang P， et al. Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus： using a new classification［J］. Med Oncol， 2012， 29： 2992- 2997.
［18］ Ando E， Tanaka M， Yamashita F， et al. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis： analysis of 48 cases［J］. Cancer， 2002， 95： 588- 595.
［19］ Ikeda M， Shimizu S， Sato T， et al. Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hep atocellular carcinoma： randomized phase Ⅱ trial［J］. Ann Oncol， 2016， 27： 2090- 2096.
［20］ He MK， Zou RH， Li QJ， et al. Phase Ⅱ study of sorafenib combined with concurrent hepatic arterial infusion of oxaliplatin， 5- fluorouracil and leucovorin for unresectable hepatocellular carcinoma with major portal vein thrombosis［J］. Cardiovasc Intervent Radiol， 2018， 41： 734- 743.

相似文献/References:

[1].关于召开“全国肝癌介入治疗研讨会”的通知[J].介入放射学杂志,1995,(04):200.
[2]杨永波,程红岩.肝动脉化疗栓塞治疗中碘油用量的现状与研究进展[J].介入放射学杂志,2012,(04):348.
　.Ｔｈｅ ｖｏｌｕｍｅ ｏｆ Ｌｉｐｉｏｄｏｌ ｕｓｅｄ ｉｎ ＴＡＣＥ： ｉｔｓ ｃｕｒｒｅｎｔ ｓｉｔｕａｔｉｏｎ ａｎｄ ｒｅｓｅａｒｃｈ ｐｒｏｇｒｅｓｓ [J].journal interventional radiology,2012,(12):348.
[3]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗３０例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
　,,et al.ＴＡＣＥ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｒａｄｉｏｆｒｅｑｕｅｎｃｙ ａｂｌａｔｉｏｎ ｆｏｒ ｍａｓｓｉｖｅ ｐｒｉｍａｒｙ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ａ ｃｌｉｎｉｃａｌ ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ [J].journal interventional radiology,2012,(12):322.
[4]敖 劲,张跃伟,徐 克. 明胶海绵微粒经动脉栓塞治疗原发性肝癌的研究现状[J].介入放射学杂志,2011,(12):1010.
　AO Jin,ZHANG Yue-wei,XU Ke..Gelatin sponge particle used as an embolic agent in transcatheter arterial chemoembolization treatment for primary hepatocellular carcinoma: its current situation in research[J].journal interventional radiology,2011,(12):1010.
[5]杜丹丹,吕维富. 肝癌射频消融后的影像学评价[J].介入放射学杂志,2012,(01):75.
　DU Dan dan,Lv Wei fu..Imaging evaluation of liver cancer after radiofrequency ablation therapy[J].journal interventional radiology,2012,(12):75.
[6]赵 艳,韩国宏,白 苇,等. 药物缓释微球肝动脉化疗栓塞治疗肝癌研究进展[J].介入放射学杂志,2012,(01):78.
　ZHAO Yan,HAN Guo-hong,BAI Wei,et al.Transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma: its research progress[J].journal interventional radiology,2012,(12):78.
[7]何海涛,刘 圣,刘建秦,等. 肝癌TACE术并发脑碘油栓塞二例并文献复习[J].介入放射学杂志,2012,(08):682.
　HE Hai- tao,LIU sheng,LIU Jian- qing,et al. Cerebral Lipiodol embolism occurred after transcatheter arterial chemoembolization for hepatocellular carcinoma: report of two cases with literature review[J].journal interventional radiology,2012,(12):682.
[8]罗中华,秦 勉,张学昕,等.原发性肝癌合并下腔静脉及右心房癌栓的动脉内化疗栓塞治疗[J].介入放射学杂志,2012,(12):1035.
　LUO Zhong? hua,QIN Mian,ZHANG Xue? xin,et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma complicated by tumor thrombus in inferior vena cava and right atrium[J].journal interventional radiology,2012,(12):1035.
[9]徐 阳,臧 爽,陈路锋,等.Logistic回归及ROC曲线综合评价血生化指标对肝癌TACE术后发热的预测价值 [J].介入放射学杂志,2013,(06):513.
　XU Yang,ZANG Shuang,CHEN Lu? feng,et al. Combination evaluation of plasma biochemical indexes with Logistic regression and ROC analysis in predicting hyperthermia after transcatheter hepatic arterial chemoembolization for liver cancer[J].journal interventional radiology,2013,(12):513.
[10]彭国文,李晓群. 射频消融及组合方案治疗特殊/高危部位肝癌的中远期疗效[J].介入放射学杂志,2013,(06):525.
　PENG Guo? wen,LI Xiao? qun.. The mid?蛳 to?蛳 long term efficacy of radiofrequency ablation together with combination regimen for the treatment of hepatic carcinomas located at special or high?蛳 risk regions[J].journal interventional radiology,2013,(12):525.
[11]张　　　磊,陆骊工,李　　　勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,(12):968.
　ZHANG Lei,LU Li-gong,LI Yong,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].journal interventional radiology,2011,(12):968.
[12]刘 岩,刘瑞宝,王 平,等. 经导管植入125I放射性粒子治疗肝癌伴门静脉癌栓19例[J].介入放射学杂志,2014,(01):35.
　LIU Yan,LIU Rui? bao,WANG Ping,et al. Percutaneous transcatheter implantation of 125iodine seeds for the treatment of liver cancer associated with portal vein tumor thrombus： initial experience in 19 cases[J].journal interventional radiology,2014,(12):35.
[13]田玉龙,刘瑞宝,刘 岩,等.双导向技术引导下125I粒子植入治疗肝癌合并门静脉癌栓[J].介入放射学杂志,2015,(09):785.
　TIAN Yu- long,LIU Rui- bao,LIU Yan,et al.25I seeds implantation using dual- guided technique for the treatment of hepatocellular carcinoma associated with portal vein tumor thrombus[J].journal interventional radiology,2015,(12):785.
[14]韦 伟,关利君.TACE联合微波消融与联合125I放射性粒子植入治疗不可切除肝癌合并门静脉癌栓疗效比较[J].介入放射学杂志,2022,31(09):889.
　WEI Wei,GUAN Lijun..TACE combined with microwave ablation and 125I radioactive seed implantation for the treatment of inoperable liver cancer with portal vein tumor thrombus[J].journal interventional radiology,2022,31(12):889.

备注/Memo

备注/Memo:
（收稿日期：２０１8-０8-11）
（本文编辑：俞瑞纲）
更新日期/Last Update: 2018-12-20